Cite
HARVARD Citation
Morabito, A. et al. (2017). A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients. Lung cancer. pp. 15-21. [Online].